Stay updated on LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial
Sign up to get notified when there's something new on the LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial page.

Latest updates to the LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial page
- CheckyesterdayChange DetectedAdded a new revision entry for version v3.5.2 and removed the previous v3.5.0 from the study record history.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check30 days agoChange Detected- Added revision entry v3.5.0 - Removed revision entry v3.4.3SummaryDifference0.1%

- Check37 days agoChange DetectedRevision history shows v3.4.3 added and v3.4.2 removed.SummaryDifference0.1%

- Check65 days agoChange DetectedA new Revision: v3.4.2 is added and the older Revision: v3.4.1 notice is removed; these are metadata changes in the page history and do not affect study data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check72 days agoChange DetectedNotice about government funding and the latest revision tag (v3.4.1) with removal of v3.4.0; these are general site updates rather than study data changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check79 days agoChange DetectedThe history page now includes a glossary toggle and color-coded change highlights (green for additions and red for deletions). It also shows update notes such as No FEAR Act Data and Revision identifiers (Revision: v3.4.0 added and v3.3.4 removed).SummaryDifference0.8%

Stay in the know with updates to LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial page.